Akcea Therapeutics, Inc. Proceeds from Issuance Initial Public Offering
Akcea Therapeutics, Inc. had Proceeds from Issuance Initial Public Offering of $132.30 million as of 2017-07-19, per its 10-K filed 2020-03-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2020-03-02
- 2017-07-19: Proceeds from Issuance Initial Public Offering $132.30M; Proceeds from Issuance Initial Public Offering as first filed $132.40M.
| Period end | Proceeds from Issuance Initial Public Offering | Proceeds from Issuance Initial Public Offering as first filed |
|---|---|---|
| 2017-07-19 | $132.30M 10-K · filed 2020-03-02 | $132.40M 10-Q · filed 2017-11-07 |